Opus Genetics(IRD)
$4.05+0.01 (+0.25%)
IRD
Opus Genetics financials statements
$4.05
At close:+0.01 (+0.25%)
Want to see IRD full AI Analyst Report?
Opus Genetics (IRD) Income Statement
1,367 Followers
Opus Genetics Income Statement
Last quarter (Q3 2026), Opus Genetics's total revenue was $1.14M, a decrease of 63.07% from the same quarter last year. In Q3, Opus Genetics's net income was $-46.49M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 14.20M | $ 10.99M | $ 19.05M | $ 39.85M | $ 589.00K | |
| $ 14.20M | $ 10.99M | $ 19.05M | $ 39.85M | $ 589.00K | |
| $ 52.80M | $ 73.07M | $ 29.61M | $ 21.62M | $ 23.29M | |
| Depreciation and Amortization | $ 53.00K | $ 10.00K | $ 6.00K | $ 4.00K | $ 4.00K |
| $ -48.07M | $ -57.52M | $ -9.97M | $ 18.22M | $ -56.69M | |
| $ -38.60M | $ -62.07M | $ -10.56M | $ 18.23M | $ -22.70M | |
| $ -10.99M | $ 4.54M | $ 589.00K | $ -23.00K | $ -33.99M | |
| $ -49.59M | $ -57.53M | $ -9.97M | $ 18.20M | $ -56.69M | |
| $ -49.59M | $ -57.53M | $ -9.99M | $ 17.89M | $ -56.69M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.80 | $ -2.15 | $ -0.46 | $ 0.90 | $ -3.82 |
| Diluted EPS | $ -0.80 | $ -2.15 | $ -0.46 | $ 0.87 | $ -3.82 |
| Weighted Average Shares Outstanding | 62.22M | 26.72M | 21.59M | 19.93M | 14.85M |
| Weighted Average Shares Outstanding (Diluted) | 62.22M | 26.72M | 21.59M | 20.60M | 14.85M |
Currency in USD

